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As with many events in the history of science, the development
of the hypothesis that acetaldehyde is a plausible psychoactive
substance with specific central effects (not related to its toxic-
ity) has not been either incremental or progressive. Rather, it has
evolved through a process of fits and starts. Initial clinical obser-
vations suggesting that accumulation of acetaldehyde could be
used as a therapy for alcoholism did not lead to a highly effective
treatment, and in fact, it was noted early on that small amounts
of ethanol consumed under these conditions (i.e., blockade of
aldehyde dehydrogenase) could be perceived as being even more
pleasurable (Chevens, 1953). Although some laboratory data in
animals appeared at that time (Carpenter and Macleod, 1952), it
took a decade for the pre-clinical studies to focus on the poten-
tial importance of acetaldehyde. Since Myers proposed in the late
60’s that acetaldehyde could be a mediator of some of the effects
of ethanol (Myers and Veale, 1969), advances in this field have
gone through a push-pull process. His seminal discoveries about
acetaldehyde self-administration and neural effects were met with
skepticism because of the lack of replicability of results at that
time, and the many unsolved questions related to measurements
of brain acetaldehyde. In the late 70’s, work conducted mainly by
Amit’s group (e.g., Amit et al., 1977), put acetaldehyde back in the
picture. To replicate some of the early discoveries and expand the
range of behaviors for which acetaldehyde could be shown to be a
mediator of ethanol’s effects, this laboratory started to assess the
impact of interfering with acetaldehyde metabolism. Again, this
work met with considerable skepticism, in part because of issues
such as the lack of penetrability of acetaldehyde into the brain
due to the high content of aldehyde dehydrogenase (ALDH) in
the blood brain barrier, and also the absence of the alcohol dehy-
drogenase (ADH) isoform that metabolizes ethanol in the brain
(Lindros and Hillbom, 1979). More or less at that time, a newly
characterized enzyme for the metabolism of ethanol was intro-
duced to the cerebral enzymatic landscape; catalase (Cohen et al.,
1980). This enzyme became the focus of the next wave of work by
Aragon and Amit related to the acetaldehyde hypothesis (Aragon
et al., 1985). In vitro and in vivo studies, mainly with one phar-
macological tool and one genetic mutation, established the first
plausible support for the idea that brain ethanol metabolism was
possible, and had a clear impact on alcohol consumption (Aragon
and Amit, 1993). In addition, late in the 90’s the localization of
high levels of catalase in catecholamine rich areas in the brain
(Zimatkin and Lindros, 1996), identified possible neuroanatom-
ical loci for acetaldehyde formation. Across the first few years of
the new century, Aragon and his colleagues developed a series of
pharmacological tools that more firmly established the idea that
brain catalase activity was directly correlated with ethanol’s stim-
ulant effects (Correa et al., 2001). Since then, data have been accu-
mulating at an expanding pace. Additional groups of researchers,
most of which are represented in this issue, started to apply dif-
ferent approaches to the “acetaldehyde hypothesis,” which led to
a new wave of papers and substantial scientific advances in this
field. Genetic, neuropharmacological, electrophysiological and
cellular mechanisms for acetaldehyde actions have been estab-
lished. Potential therapeutic tools have been used. Neural circuits
and complex behaviors have been studied, and other mediators
of ethanol’s actions that depend upon acetaldehyde formation,
metabolism, or conjugation have been analyzed.
The present group of articles provides a comprehensive and
up-to-date overview of research related to the actions of acetalde-
hyde, with recent results from the many groups that have deci-
sively contributed to the field. The first review by Peana and
Acquas gives a clear perspective on the behavioral evidence show-
ing how acetaldehyde is a neuroactive molecule able to exert
key motivational effects that can lead to the development of
addiction, and also explains the neurobiochemical correlates of
those actions in different intracellular signaling systems and
diverse brain areas. A special accent on acetaldehyde formation,
metabolism and blockade in relation to its reinforcing charac-
teristics is presented by Diana and colleagues. Emphasis is put
on the use of thiol compounds, which sequester acetaldehyde,
as therapeutic agents preventing those effects. A very interest-
ing methodological approach using gene-specific manipulations
to change enzymatic activity, both in the liver and in the brain,
has led Israel and colleagues to explore the behavioral conse-
quences of central versus peripheral acetaldehyde metabolism.
Direct administration of ethanol or acetaldehyde either in the
periphery or in the brain, as employed in the studies from Correa
and Salamone’s lab, describe c-Fos expression (a marker of neu-
ral activity) across a broad range of brain areas involved in the
motivational actions of both compounds. At the molecular level,
Weiger and colleagues present data indicating that acetaldehyde
acts on maxi calcium-activated potassium channels, a key factor
in electrical stimulation of neural cells.
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The role of acetaldehyde/monoamine conjugates that form
tetrahydroisoquinoline alkaloids is presented in the next group
of articles. Special attention is paid to the conjugate of acetalde-
hyde with dopamine, salsolinol. This molecule has demonstrated
to be central for the actions of ethanol in the mesolimbic sys-
tem (Melis et al., 2013). Electrophysiological data presented by
Xie, Ye and colleagues show how salsolinol modulates firing of
dopamine neurons in brain slices from posterior ventral tegmen-
tal area via activation of opioid receptors located in neighboring
GABAergic neurons. These data are discussed by Polache and
Granero in a commentary, written from the perspective of their
own extensive research on salsonilol-induced dopamine release
in the accumbens in behaving animals. Deehan and Rodd, report
on the role of salsonilol and other conjugates in acetaldehyde
self-administration, in an integrative review of human find-
ings and their own key animal data involving the mesolimbic
dopaminergic system.
Although dopamine has been a major focus for studies of
acetaldehyde’s central actions, other neural systems are also
involved. For instance, the role of the opioid system in the neu-
rochemical and behavioral effects of acetaldehyde is reviewed by
Font and Pastor, who not only discuss the effects of salsonilol on
mu opiod receptors, but also summarize what is known about
acetaldehyde formation in brain nuclei rich in catalase and beta-
endorphine neurons. Elegant studies conducted by Cannizzaro’s
laboratory demonstrate that the endocannabinoid system mod-
ulates not only operant acetaldehyde self-administration, extinc-
tion, and relapse, but also its effects on the emission of punished
responses during conflict experiments, all of which are key fea-
tures of addiction. A relevant role for acetate, a metabolite of
acetaldehyde, as a mediator of the sedative and ataxic effects of
alcohol is presented by Correa and colleagues. These results are
hypothesized to be mediated by the neuromodulator adenosine.
The work byMarch,Molina and colleagues is focused on a par-
ticulary important neurodevelopemental period; early ontogeny.
At this stage, drugs have a substantial impact on the nervous sys-
tem, and in the case of ethanol, its actions can be affected by the
fact that rats show a high rate of brain catalase activity specifi-
cally in this period. Thus, these authors provide extensive results
about vulnerability to abuse and addiction in newborn and infant
rats, which is induced by early ethanol and acetaldehyde exposure.
These data are discussed in a commentary by Zimatkin, an expert
on brain enzymatic localization, in terms of the ideal scenario
in brain pups for acetaldehyde accumulation (high catalase-low
ALDH). Finally, on the other extreme of the neurodevelopmental
process, Vaglini, Corsini and colleagues review data on the impact
of acetaldehyde on Parkinson’s desease. In this case the authors
focus on the role of the other important brain enzymatic sys-
tem for the central formation and degradation of acetaldehyde;
cytochrome P450-2E1, which is highly concentrated in substan-
tia nigra pars compacta, an area rich in dopamine cell bodies.
Acetaldehyde acting as a substrate/inhibitor of this enzyme, may
facilitate the susceptibility of these dopaminergic neurons to
toxin-induced parkinsonism.
Many more exciting discoveries are yet to come, and new
methodologies still need to be developed in order to overcome
the obstacles that continue to obscure our understanding of the
role of acetaldehyde. Especially important would be the need
for reliable measurements of central acetaldehyde production
under physiological conditions. However, we can certainly say
that acetaldehyde, its metabolites and its conjugates are critical
molecules for the complex set of effects observed after ethanol
consumption, especially those related to the development of its
pathological consumption.
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